NCT02656524View on ClinicalTrials.gov

Stivarga Real Life Evidence in Hungary

CompletedOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

February 15, 2017

Study Completion Date

February 15, 2017

Conditions

Colorectal Neoplasms

Interventions

DRUG

Regorafenib (Stivarga, BAY73-4506)

Product is used in accordance with SmPC

Trial Locations (1)

Unknown

Budapest

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY